MEF2A and renal cell carcinoma: In our study, we have determined that MEF2A exerts inhibitory effects on RCC progression by inducing cell cycle arrest at the G1/S phase, facilitating apoptosis of RCC cells and suppressing the Wnt/β‐catenin signalling pathway.